Detailansicht

Wissensnetz

Person

Adhara Lazaro (1978-)

Ärztin

Name	Adhara Lazaro
Zeit	1978- (Lebensdaten)
Ort	Manila (Geburtsort) Philippinen
Beruf	Ärztin (charakteristischer Beruf)
Weitere Angaben	Diss. 2018, Albert-Ludwigs-Universität Freiburg i. Br., Medizinische Fakultät
Datensatztyp	Person
GND-Nummer	1162502010
Datensatz-ID	1162502010
Beteiligt an alle anzeigen Close relationship between systemic arterial and portal venous pressure in an animal model with healthy liver Case report: assessing COVID-19 transmission in professional volleyball in Germany, September to December 2020: an epidemiological study Esophageal lichen planus: Current knowledge, challenges and future perspectives Cyclic GMP in liver cirrhosis - role in pathophysiology of portal hypertension and therapeutic implications Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension : : a case report with 8 years follow-up Correlation between Mean Arterial Pressure (MAP) and Portal Venous Pressure (PVP) in rats

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Adhara Lazaro (1978-)

Close relationship between systemic arterial and portal venous pressure in an animal model with healthy liver

Case report: assessing COVID-19 transmission in professional volleyball in Germany, September to December 2020: an epidemiological study

Esophageal lichen planus: Current knowledge, challenges and future perspectives

Cyclic GMP in liver cirrhosis - role in pathophysiology of portal hypertension and therapeutic implications

Phosphodiesterases in the liver as potential therapeutic targets of cirrhotic portal hypertension

Comprehensive lifestyle intervention vs soy protein-based meal regimen in non-alcoholic steatohepatitis

Beneficial long term effect of a phosphodiesterase-5-inhibitor in cirrhotic portal hypertension : : a case report with 8 years follow-up

Correlation between Mean Arterial Pressure (MAP) and Portal Venous Pressure (PVP) in rats